Regenerative Pharmaceuticals executives said the company expects to launch critical clinical trials of REGN 20423 in late 2027 or early 2028.

Zhitongcaijing · 1d ago
Regenerative Pharmaceuticals executives said the company expects to launch critical clinical trials of REGN 20423 in late 2027 or early 2028.